JP Morgan Chase’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-403
Closed -$6.15K 7607
2025
Q4
$6.15K Hold
403
﹤0.01% 6777
2025
Q3
$6K Buy
+403
New +$5.84K ﹤0.01% 6744
2023
Q4
Sell
-9,934
Closed -$136K 7580
2023
Q3
$136K Sell
9,934
-5,168
-34% -$73.1K ﹤0.01% 5302
2023
Q2
$213K Sell
15,102
-7,116
-32% -$103K ﹤0.01% 5041
2023
Q1
$326K Buy
22,218
+17,899
+414% +$272K ﹤0.01% 4756
2022
Q4
$67K Buy
+4,319
New +$65.5K ﹤0.01% 5508

Other funds holding DIAX

JP Morgan Chase's DIAX Position: Q1 2026 in Review

JP Morgan Chase sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q1 2026, closing a stake of 403 shares — an estimated $6.15K sold.

JP Morgan Chase first reported a position in DIAX in Q4 2022 and held it in 6 quarters. The position peaked at $326K in Q1 2023. 3 funds tracked by Wall St. Rank hold DIAX as of Q1 2026.

  • JP Morgan Chase reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q1 2026 after selling out during the quarter.
  • JP Morgan Chase sold 403 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q1 2026, an estimated $6.15K.
  • JP Morgan Chase first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q4 2022 and held it in 6 quarters.
  • JP Morgan Chase's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $326K in Q1 2023.
  • 3 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.